| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.16 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.11 | 0.5 |